PRA Health Sciences, Inc. (PRAH) financial statements (2022 and earlier)

Company profile

Business Address 4130 PARKLAKE AVENUE
RALEIGH, NC 27612
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments690506336168151236182
Cash and cash equivalents690506336168151236182
Restricted cash and investments    000
Receivables779844709733692659703
Other current assets126 89111112 76
Other undisclosed current assets 110   91 
Total current assets:1,5961,4611,1341,012955986961
Noncurrent Assets
Operating lease, right-of-use asset170178179182185186182
Property, plant and equipment192195192189185181177
Intangible assets, net (including goodwill)2,2722,2912,2852,2892,3062,1412,134
Goodwill1,6901,6911,6721,6601,6601,5031,485
Intangible assets, net (excluding goodwill)581600613628646639649
Deferred income tax assets 15   10 
Other noncurrent assets53374952503747
Other undisclosed noncurrent assets 3   3 
Total noncurrent assets:2,6872,7182,7052,7112,7262,5592,540
TOTAL ASSETS:4,2834,1793,8393,7233,6813,5443,500
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4621232435818159
Accounts payable46573243585559
Employee-related liabilities 150   119 
Taxes payable 3   2 
Interest and dividends payable 2   5 
Deferred revenue733733580549534506475
Debt116252525876335
Other liabilities 43   45 
Other undisclosed current liabilities427253363413347223304
Total current liabilities:1,3231,2661,0001,0311,0271,017873
Noncurrent Liabilities
Long-term debt and lease obligation1,3031,3181,4171,4281,4391,3131,558
Long-term debt, excluding current maturities1,1531,1591,2561,2621,2681,1401,388
Operating lease, liability151159161166171172170
Liabilities, other than long-term debt100116979710812549
Deferred income tax liabilities486348496179 
Other liabilities52524947474649
Other undisclosed noncurrent liabilities      74
Total noncurrent liabilities:1,4041,4331,5141,5251,5471,4371,681
Total liabilities:2,7262,6992,5142,5552,5742,4542,554
Stockholders' equity
Stockholders' equity attributable to parent1,5571,4791,3251,1671,1071,090947
Common stock1111111
Additional paid in capital1,1741,1371,0891,0591,0271,006975
Accumulated other comprehensive loss(115)(99)(154)(190)(204)(160)(198)
Retained earnings497440389298284243168
Total stockholders' equity:1,5571,4791,3251,1671,1071,090947
TOTAL LIABILITIES AND EQUITY:4,2834,1793,8393,7233,6813,5443,500

Income statement (P&L) ($ in millions)

3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
Revenues934873796730784800781
Gross profit:934873796730784800781
Operating expenses(123)(121)(115)(110)(107)(104)(96)
Other undisclosed operating loss(741)(656)(557)(576)(614)(595)(589)
Operating income:7097124446310196
Nonoperating income (expense)12(13)(9)(11)8(4)5
Foreign currency transaction gain (loss), before tax12(13)(9)(11)8(4)5
Interest and debt expense(0)1  (0)1 
Other undisclosed loss from continuing operations before equity method investments, income taxes (43)   (17)(15)
Income from continuing operations before equity method investments, income taxes:814111533718186
Other undisclosed income (loss) from continuing operations before income taxes(5)35(11)(12)(13)  
Income from continuing operations before income taxes:777610421588186
Income tax expense(20)(25)(13)(7)(17)(6)(3)
Net income available to common stockholders, diluted:57519114417583

Comprehensive Income ($ in millions)

3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
Net income:57519114417583
Other comprehensive income (loss)  3614(44) (27)
Other undisclosed comprehensive income 55   37 
Comprehensive income (loss):5710612728(3)11256
Other undisclosed comprehensive loss, net of tax, attributable to parent(17)      
Comprehensive income (loss), net of tax, attributable to parent:4010612728(3)11256

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: